<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>STTR Phase I:  Dermatologist-level detection of suspicious pigmented skin lesions from high-resolution full-body images</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>08/01/2021</AwardEffectiveDate>
<AwardExpirationDate>07/31/2022</AwardExpirationDate>
<AwardTotalIntnAmount>255999.00</AwardTotalIntnAmount>
<AwardAmount>255999</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Henry Ahn</SignBlockName>
<PO_EMAI>hahn@nsf.gov</PO_EMAI>
<PO_PHON>7032927069</PO_PHON>
</ProgramOfficer>
<AbstractNarration>The broader impact/commercial potential of this Small Business Technology Transfer Program (STTR) Phase I project is to improve outcomes in dermatology and enable improved clinical care in the absence of specialists.  The proposed technology enables cost-effective screening for cancer, psoriasis, atopic dermatitis, and other inflammatory skin conditions. In the United States, psoriasis affects about 8 million people while about 31.6 million people in the United States have some form of eczema, including atopic dermatitis. The proposed system generates a highly magnified image of the skin for analysis by a clinician or an artificial-intelligence based automated system. &lt;br/&gt;&lt;br/&gt;This Small Business Technology Transfer Program (STTR) Phase I project integrates several subsystems: 1) a scanner and software to capture and reconstruct super high-resolution (dermatoscope level) model of the entire skin surface of patients in a matter of minutes; 2) a multispectral illumination system to provide more information than currently available from a typical white-light systems, potentially leading to superior sensitivity and specify in lesion detection and classification; and 3) a system to find and classify lesions automatically from high-resolution images.  This system advances the automated classification of images beyond those filtered previously by a clinician. Moreover, the system's UV illuminations system potentially can be used in a photodynamic treatment regimen.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.</AbstractNarration>
<MinAmdLetterDate>07/20/2021</MinAmdLetterDate>
<MaxAmdLetterDate>07/20/2021</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2127051</AwardID>
<Investigator>
<FirstName>Mehran</FirstName>
<LastName>Armand</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Mehran Armand</PI_FULL_NAME>
<EmailAddress>mehran.armand@jhuapl.edu</EmailAddress>
<PI_PHON>4439759950</PI_PHON>
<NSF_ID>000602597</NSF_ID>
<StartDate>07/20/2021</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Davood</FirstName>
<LastName>Tashayyod</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Davood Tashayyod</PI_FULL_NAME>
<EmailAddress>davood@lumoscan.com</EmailAddress>
<PI_PHON>2023681216</PI_PHON>
<NSF_ID>000766446</NSF_ID>
<StartDate>07/20/2021</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>LUMO IMAGING LLC</Name>
<CityName>POTOMAC</CityName>
<ZipCode>208541512</ZipCode>
<PhoneNumber>2023681216</PhoneNumber>
<StreetAddress>10801 PLEASANT HILL DR</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Maryland</StateName>
<StateCode>MD</StateCode>
<CONGRESSDISTRICT/>
<CONGRESS_DISTRICT_ORG/>
<ORG_DUNS_NUM>108194956</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>LUMO IMAGING LLC</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Lumo Imaging LLC]]></Name>
<CityName>Rockville</CityName>
<StateCode>MD</StateCode>
<ZipCode>208500395</ZipCode>
<StreetAddress><![CDATA[155 Gibbs Street, Suite 530]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Maryland</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>08</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF/>
</Performance_Institution>
<ProgramElement>
<Code>1505</Code>
<Text>STTR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>004E</Code>
<Text>BIOMEDICAL ENG AND DIAGNOSTICS</Text>
</ProgramReference>
<Appropriation>
<Code>0121</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2021~255999</FUND_OBLG>
</Award>
</rootTag>
